About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Botulinum toxin a
- Procedure number
- PSUSA/00000426/201812
- Regulatory outcome
- Variation
Documents
Botulinum toxin a: List of nationally authorised medicinal products - PSUSA/00000426/201812
English (EN) (209.94 KB - PDF)
Botulinum toxin a: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000426/201812
English (EN) (26.91 KB - PDF)
български (BG) (94.79 KB - PDF)
español (ES) (29.16 KB - PDF)
čeština (CS) (101.07 KB - PDF)
dansk (DA) (32.86 KB - PDF)
Deutsch (DE) (26.19 KB - PDF)
eesti keel (ET) (27.42 KB - PDF)
ελληνικά (EL) (95.57 KB - PDF)
français (FR) (32.24 KB - PDF)
hrvatski (HR) (89.49 KB - PDF)
íslenska (IS) (24.82 KB - PDF)
italiano (IT) (34.89 KB - PDF)
latviešu valoda (LV) (99.86 KB - PDF)
lietuvių kalba (LT) (95.89 KB - PDF)
magyar (HU) (88.69 KB - PDF)
Malti (MT) (101.42 KB - PDF)
Nederlands (NL) (31.87 KB - PDF)
norsk (NO) (56.31 KB - PDF)
polski (PL) (96.67 KB - PDF)
português (PT) (32.13 KB - PDF)
română (RO) (100.59 KB - PDF)
slovenčina (SK) (100.04 KB - PDF)
slovenščina (SL) (96.94 KB - PDF)
Suomi (FI) (25.89 KB - PDF)
svenska (SV) (32.05 KB - PDF)